AdvertisementFDA-Approved Knock-Offs Of Biotech Drugs Could Safely Save Big BucksAugust 01, 2016Alison KodjakfacebookEmailIn 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. (AFP/Getty Images)
